Research groups

Tumor Immunology

Research aim

Our research aims to revolutionise cancer treatment by advancing innovative immunotherapies, ensuring safer, more effective therapies, and improving patient outcomes, ultimately transforming lives through cutting-edge translational cancer research.

Go to group

Recent publications

Disrupting the balance between activating and inhibitory receptors of γδT cells for effective cancer immunotherapy Dennis X Beringer, Trudy Straetemans, Susana Minguet, Caterina Riillo, Lydia Lynch, Zsolt Sebestyen, Jürgen Kuball
Nature Reviews Cancer, 2025, vol. 25, p.590-612
Unusual Partners Konstantinos Vazaios, Patricia Hernández López, Tineke Aarts-Riemens, Annet Daudeij, Vera Kemp, Rob C. Hoeben, Trudy Straetemans, Esther Hulleman, Friso G. Calkoen, Jasper van der Lugt, Jürgen Kuball
International Journal of Molecular Sciences, 2025, vol. 26
Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells Patricia Hernández-López, Eline van Diest, Peter Brazda, Sabine Heijhuurs, Angelo Meringa, Lauren Hoorens van Heyningen, Caterina Riillo, Caroline Schwenzel, Marina Zintchenko, Inez Johanna, Mara J T Nicolasen, Astrid Cleven, Thomas A Kluiver, Rosemary Millen, Jiali Zheng, Froso Karaiskaki, Trudy Straetemans, Hans Clevers, Remco de Bree, Hendrik G Stunnenberg, Weng Chuan Peng, Jeanine Roodhart, Susana Minguet, Zsolt Sebestyén, Dennis X Beringer, Jürgen Kuball
Nature immunology, 2023, vol. 25, p.88-101
Basics of advanced therapy medicinal product development in academic pharma and the role of a GMP simulation unit I. Johanna, A. Daudeij, F. Devina, C. Nijenhuis, B. Nuijen, B. Romberg, C. de Haar, J. Haanen, H. Dolstra, E. Bremer, Z. Sebestyen, T. Straetemans, I. Jedema, J. Kuball
Immuno-Oncology and Technology, 2023, vol. 20
Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies A D Meringa, P Hernández-López, A Cleven, M de Witte, T Straetemans, J Kuball, D X Beringer, Z Sebestyen
Frontiers in Immunology, 2023, vol. 14, p.1-7
Uncovering the mode of action of engineered T cells in patient cancer organoids Johanna F. Dekkers, Maria Alieva, Astrid Cleven, Farid Keramati, Amber K.L. Wezenaar, Esmée J. van Vliet, Jens Puschhof, Peter Brazda, Inez Johanna, Angelo D. Meringa, Heggert G. Rebel, Maj Britt Buchholz, Mario Barrera Román, Amber L. Zeeman, Sam de Blank, Domenico Fasci, Maarten H. Geurts, Annelisa M. Cornel, Else Driehuis, Rosemary Millen, Trudy Straetemans, Mara J.T. Nicolasen, Tineke Aarts-Riemens, Hendrikus C.R. Ariese, Hannah R. Johnson, Ravian L. van Ineveld, Froso Karaiskaki, Oded Kopper, Yotam E. Bar-Ephraim, Kai Kretzschmar, Alexander M.M. Eggermont, Stefan Nierkens, Ellen J. Wehrens, Henk G. Stunnenberg, Hans Clevers, Jürgen Kuball, Zsolt Sebestyen, Anne C. Rios
Nature Biotechnology, 2022, vol. 41, p.60-69